ID

14769

Beschrijving

PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe); ODM derived from: https://clinicaltrials.gov/show/NCT02269813

Link

https://clinicaltrials.gov/show/NCT02269813

Trefwoorden

Versies (1)
  1. 27-04-16 27-04-16 -
Geüploaded op

27 april 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT02269813

Engels

Eligibility Breast Cancer NCT02269813

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
women with histologically proven invasive stage 1 and 2 breast cancer
Beschrijving

Gender | Invasive breast carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0853879
hormone receptor positive according to local standards
Beschrijving

Hormone Receptor Positive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C1446409
her2 negative - i.e. ihc 0-1+, or fish or other ish non-amplified (locally assessed)
Beschrijving

Human epidermal growth factor 2 negative carcinoma of breast | Immunohistochemistry | Fluorescent in Situ Hybridization

Datatype

boolean

Alias
UMLS CUI [1]
C2316304
UMLS CUI [2]
C0021044
UMLS CUI [3]
C0162789
axillary lymph node status: 0-3 involved (macro metastases i.e. >2mm or micro metastases i.e. >0.2-2mm)
Beschrijving

axillary lymph node Status | Macrometastasis | Neoplasm Micrometastasis

Datatype

boolean

Alias
UMLS CUI [1,1]
C1279048
UMLS CUI [1,2]
C0449438
UMLS CUI [2]
C3829229
UMLS CUI [3]
C1513276
≥ 18 years of age at time of consent
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
patients must be eligible to receive adjuvant chemotherapy and endocrine therapy as defined by a good karnofsky index, no hematological, cardiological or hepatic contraindications nor any impeding comorbidity
Beschrijving

eligible Adjuvant Chemotherapy Hormone Therapy | Karnofsky Performance Status | Medical contraindication Hematological Disease Heart Diseases Liver diseases | Comorbidity

Datatype

boolean

Alias
UMLS CUI [1,1]
C1548635
UMLS CUI [1,2]
C0085533
UMLS CUI [1,3]
C0279025
UMLS CUI [2]
C0206065
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0018939
UMLS CUI [3,3]
C0018799
UMLS CUI [3,4]
C0023895
UMLS CUI [4]
C0009488
written informed consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
≥4 involved axillary nodes
Beschrijving

Axillary lymph node group

Datatype

boolean

Alias
UMLS CUI [1]
C0729594
multi-centric disease with more than 2 clinically relevant lesions
Beschrijving

Multicentric Breast Carcinoma Lesion

Datatype

boolean

Alias
UMLS CUI [1,1]
C2986664
UMLS CUI [1,2]
C0221198
hr negative or her2 positive/amplified (locally assessed)
Beschrijving

Hormone Receptor Negative | HER2-positive carcinoma of breast

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0205160
UMLS CUI [2]
C1960398
previous diagnosis of malignancy unless disease free for 10 years
Beschrijving

Prior diagnosis Malignant Neoplasms

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332132
UMLS CUI [1,2]
C0006826
metastatic disease
Beschrijving

Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C0027627
tumor sample shipped to agendia with ≤ 30% tumor cells or that fails qa or qc criteria
Beschrijving

Tumor tissue sample | quality assurance | quality control

Datatype

boolean

Alias
UMLS CUI [1]
C0475358
UMLS CUI [2]
C0178932
UMLS CUI [3]
C0034378
women who have started or completed adjuvant chemotherapy or neo-adjuvant chemotherapy for current breast cancer
Beschrijving

Gender | Adjuvant Chemotherapy Breast Carcinoma | Neoadjuvant Therapy Breast Carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0085533
UMLS CUI [2,2]
C0678222
UMLS CUI [3,1]
C0600558
UMLS CUI [3,2]
C0678222
Terug naar het begin van de pagina

Similar models

Eligibility Breast Cancer NCT02269813

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Invasive breast carcinoma
Item
women with histologically proven invasive stage 1 and 2 breast cancer
boolean
C0079399 (UMLS CUI [1])
C0853879 (UMLS CUI [2])
Hormone Receptor Positive
Item
hormone receptor positive according to local standards
boolean
C0019929 (UMLS CUI [1,1])
C1446409 (UMLS CUI [1,2])
Human epidermal growth factor 2 negative carcinoma of breast | Immunohistochemistry | Fluorescent in Situ Hybridization
Item
her2 negative - i.e. ihc 0-1+, or fish or other ish non-amplified (locally assessed)
boolean
C2316304 (UMLS CUI [1])
C0021044 (UMLS CUI [2])
C0162789 (UMLS CUI [3])
axillary lymph node Status | Macrometastasis | Neoplasm Micrometastasis
Item
axillary lymph node status: 0-3 involved (macro metastases i.e. >2mm or micro metastases i.e. >0.2-2mm)
boolean
C1279048 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C3829229 (UMLS CUI [2])
C1513276 (UMLS CUI [3])
Age
Item
≥ 18 years of age at time of consent
boolean
C0001779 (UMLS CUI [1])
eligible Adjuvant Chemotherapy Hormone Therapy | Karnofsky Performance Status | Medical contraindication Hematological Disease Heart Diseases Liver diseases | Comorbidity
Item
patients must be eligible to receive adjuvant chemotherapy and endocrine therapy as defined by a good karnofsky index, no hematological, cardiological or hepatic contraindications nor any impeding comorbidity
boolean
C1548635 (UMLS CUI [1,1])
C0085533 (UMLS CUI [1,2])
C0279025 (UMLS CUI [1,3])
C0206065 (UMLS CUI [2])
C1301624 (UMLS CUI [3,1])
C0018939 (UMLS CUI [3,2])
C0018799 (UMLS CUI [3,3])
C0023895 (UMLS CUI [3,4])
C0009488 (UMLS CUI [4])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Axillary lymph node group
Item
≥4 involved axillary nodes
boolean
C0729594 (UMLS CUI [1])
Multicentric Breast Carcinoma Lesion
Item
multi-centric disease with more than 2 clinically relevant lesions
boolean
C2986664 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
Hormone Receptor Negative | HER2-positive carcinoma of breast
Item
hr negative or her2 positive/amplified (locally assessed)
boolean
C0019929 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
C1960398 (UMLS CUI [2])
Prior diagnosis Malignant Neoplasms
Item
previous diagnosis of malignancy unless disease free for 10 years
boolean
C0332132 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Neoplasm Metastasis
Item
metastatic disease
boolean
C0027627 (UMLS CUI [1])
Tumor tissue sample | quality assurance | quality control
Item
tumor sample shipped to agendia with ≤ 30% tumor cells or that fails qa or qc criteria
boolean
C0475358 (UMLS CUI [1])
C0178932 (UMLS CUI [2])
C0034378 (UMLS CUI [3])
Gender | Adjuvant Chemotherapy Breast Carcinoma | Neoadjuvant Therapy Breast Carcinoma
Item
women who have started or completed adjuvant chemotherapy or neo-adjuvant chemotherapy for current breast cancer
boolean
C0079399 (UMLS CUI [1])
C0085533 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0600558 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial